Elai Davicioni, PhD
President & CSO, Director

Elai DavicioniDr. Davicioni trained as a pathobiologist in the genomics laboratory of Professor Triche before becoming an entrepreneur, raising over $20M in grant funding and equity financing to launch GenomeDx. Elai’s research in cancer biology and bioinformatics in oncology with collaborators at the Children’s Oncology Group provided the experience for applying this know-how to other malignancies. Dr. Davicioni received his BSc in chemistry, MSc in biophysics at Ben Gurion University and PhD in pathobiology from the University of Southern California and previously worked in oncology biomarkers at Compugen, a leading Israeli computational biology company. At GenomeDx, Elai establishes collaborations with leading clinicians and researchers in urologic oncology to develop an ecosystem for genomics research and create a unique user experience for clinicians and patients using genomic information.

Doug Dolginow, MD
Medical Director

Doug DolginowDr. Dolginow is a board-certified clinical pathologist and experienced molecular diagnostics executive. Doug has been a founder and senior executive in numerous biotechnology and personalized medicine companies including Nichols Specialty Laboratories, OncoMed, GeneLogic and Veracyte. He has raised over $500M in financing and developed and executed business plans, strategic partnerships and deals for his companies. Dr. Dolginow received his BA from Harvard University and an MD from the University of Kansas. He has served as medical director for several clinical laboratories and is on the clinical faculty at the University of California, San Francisco. Doug’s vision in the personalized medicine arena is to build and grow innovative, capital-efficient companies to commercialize transformative medical products using genomic information.

Adam Chinnock
General Counsel and VP Legal Affairs

Mr. Chinnock has been our General Counsel and Vice President, Legal Affairs since October 2016. Prior to joining GenomeDx, Mr. Chinnock served in roles of increasing responsibility at Arena Pharmaceuticals, Inc., a publicly traded biotechnology company, from 2002 to August 2016, most recently as Vice President & Associate General Counsel, Corporate & Compliance. Prior to Arena, Mr. Chinnock was an attorney in the Business and Finance Group of Morgan, Lewis & Bockius LLP, an international law firm. Mr. Chinnock holds a B.A. in Economics, a B.A. in English and a J.D. from the University of California, Davis.

Toni Wayne
Vice President, Human Resources

Prior to joining Genome Dx, Toni was Vice President of Human Resources at Epic Sciences, where she was a member of the senior management team. From 2004 through 2014, she served as Vice President of Human Resources at Prometheus Laboratories, leading all aspects of human resources for the company’s diagnostic and therapeutic businesses. In 2010 she was honored as a San Diego Human Resources Professional of the Year for privately-held mid-sized companies. Prior to Prometheus, she held the position of Vice President of Human Resources for Baxter Healthcare’s BioScience division, where she directed Human Resources for the division’s North American operations, and, ultimately, for the division’s global Research and Development and Commercial Operations. Toni also served as Vice President of Human Resources for Elan’s Biopharmaceutical division. She started her career in biotech with Hybritech Incorporated, where she held varying positions of management responsibility in Human Resources, Manufacturing, Quality and Project Management.

She holds her B.A. in Biological Sciences from University of California, San Diego, and Senior Professional Human Resources (SPHR) certification through the Society of Human Resources Management.